Department of Health, KP and Novo Nordisk announces the launch of Changing Diabetes® Mobile Clinic
Lahore (Muhammad Yasir) The Department of Health, Khyber Pakhtunkhwa, under its project of Extension D-Talk and IFL (Insulin for life), announced the launch of Changing Diabetes® Mobile Clinic in collaboration with Novo Nordisk Pharma (Pvt.) Ltd. at a Press Conference held at the Chief Minister House, KP in the presence of Chief Minister, Mr Mahmood Khan, Health Minister, Dr Hisham Iman Ullah, Secretary Health, KP, Mr M. Yahya Akhunzada, and Special Secretary Health, Dr Syed Farooq Jameel.
Addressing the Press Conference, Dr Hisham Iman Ullah said “Diabetes is a situation that needs to be addressed urgently as it poses a great burden on the economy of Pakistan. An initiative like Changing Diabetes® Mobile Clinic is certainly a step in the right direction”.
The Project Director, Prof. Dr A.H Aamir, shared that the objective of this collective initiative is to improve diabetes related outcomes through mutual collaboration and understanding of the local unmet needs of people with diabetes in the territorial areas of Khyber Pakhtunkhwa.
“As a collaborative partner, our focus is to create awareness by informing general public about diabetes and play our part in reducing the risk of complications associated with diabetes”, said Mr Emil Kongshøj Larsen, the Corporate Vice President of Novo Nordisk, who was also present at the occasion. At the same time, Mr Rashed Rafique, Vice President & General Manager of Novo Nordisk Pharma (Pvt) Ltd. expressed his views saying “Novo Nordisk in Pakistan is always at the forefront of improving diabetes care and this initiative is a depiction of our commitment to improve the lives of people with diabetes in the country”.
The Changing Diabetes® Mobile Clinic will operate under supervision of Prof. Dr. A.H Aamir, Project Director, Extension D-Talk and Insulin for Life , a project of Health Department, Government of KP, across Khyber Pakhtunkhuwa.
Novo Nordisk is a global healthcare company with more than 95 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat obesity, haemophilia, growth disorders and other serious chronic diseases. Headquartered in Denmark, Novo Nordisk employs approximately 41,600 people in 80 countries and markets its products in more than 170 countries. For more information, visit novonordisk.com, Facebook, Twitter, LinkedIn, YouTube.